Scientists are excitedly investigating retatrutide, a innovative treatment created by Eli Lilly, as a significant advance in physique loss . Unlike many existing approaches, retatrutide is a twin-action compound targeting both GLP-1 and GIP, hormones that affect hunger and glucose control . Prel